Why the Thyroid Contains More Selenium Than Any Other Organ
Selenium is a trace mineral incorporated into selenoproteins — proteins that contain selenium as selenocysteine at their active sites. The thyroid gland contains more selenium per gram of tissue than any other organ, and selenoproteins are critical for thyroid hormone synthesis, protection of thyroid cells from oxidative damage, and conversion of T4 (the storage form) to T3 (the active form). Selenium deficiency impairs thyroid function and can cause subclinical hypothyroidism even when TSH appears normal, because without adequate selenoproteins, the thyroid cannot produce or activate hormones efficiently.
Hashimoto’s and Autoimmune Thyroiditis
Selenium supplementation at 200mcg daily has been shown in multiple randomised trials to reduce thyroid peroxidase (TPO) antibodies — the markers of autoimmune attack on the thyroid — by 20-40% within three months. In Hashimoto’s thyroiditis (the most common cause of hypothyroidism in developed countries), reducing antibody titres is clinically meaningful because high antibody levels predict progression of gland destruction. Selenium is one of the few interventions with strong evidence for reducing autoimmune thyroid inflammation.
Cognitive Protection and Neurodegeneration
The brain is exceptionally vulnerable to oxidative damage due to its high lipid content and metabolic rate. Selenoproteins — particularly glutathione peroxidases and selenoprotein P — provide critical antioxidant protection in neural tissue. Epidemiological studies consistently find that low selenium status is associated with faster cognitive decline and higher Alzheimer’s risk. While interventional trials in healthy people have shown mixed cognitive benefits, trials in selenium-deficient populations show substantial improvements in cognitive function with supplementation.
Selenomethionine vs Sodium Selenite
The two most common supplemental forms are selenomethionine (organic, from selenised yeast) and sodium selenite (inorganic). Selenomethionine is absorbed via methionine transport pathways and incorporated into body protein stores, providing a slow-release mechanism. Sodium selenite is reduced to selenide in the gut and absorbed more rapidly but cleared faster. Comparative trials show selenomethionine raises plasma selenium more effectively than sodium selenite at equivalent doses, making it the preferable form for long-term maintenance of selenoprotein activity rather than acute correction of frank deficiency.
Why Selenium Status Matters for Thyroid Patients
Selenium deficiency impairs both antioxidant defence and thyroid hormone activation. In people with Hashimoto’s thyroiditis, selenium supplementation at 200mcg/day (as selenomethionine) has been shown to reduce anti-TPO antibodies by approximately 40% in randomised controlled trials, with concurrent reductions in thyroiditis activity. The mechanism involves reduced oxidative stress in the thyroid gland and modulation of the autoimmune response. For anyone with subclinical or clinical hypothyroidism alongside elevated thyroid antibodies, selenium status assessment and correction is a logical early intervention before escalating thyroid hormone replacement.
The Science Behind Methylene Blue Nootropic Effects
Methylene blue is a phenothiazine dye that has been used in medicine for over 140 years — initially as an antimalarial, later as a treatment for methemoglobinemia and cyanide poisoning. Its nootropic properties emerged from observations that at low doses (0.5-4 mg/kg), it acts as an electron donor in the mitochondrial electron transport chain, specifically at Complex I (NADH dehydrogenase). By donating electrons directly to Complex I, methylene blue improves the efficiency of ATP production in neurons, reduces reactive oxygen species generation at Complex III, and enhances mitochondrial respiration. This is particularly relevant for neurons because they are highly energy-dependent and particularly vulnerable to mitochondrial dysfunction.
Memory and Long-Term Potentiation
Studies on animal models demonstrate that methylene blue at low doses enhances long-term potentiation (LTP) — the cellular basis of memory formation in the hippocampus. Methylene blue increases mitochondrial biogenesis in hippocampal neurons, improves calcium handling, and enhances synaptic plasticity-related gene expression. In humans, preliminary studies suggest improvements in short-term memory, working memory, and attention, particularly in tasks requiring sustained concentration. A 2015 study found that methylene blue improved fMRI BOLD signal in the prefrontal cortex during working memory tasks, suggesting increased neural efficiency in the circuits most important for executive function.
Safety and Legality
Methylene blue is FDA-approved for the treatment of methemoglobinemia and is available by prescription. As an over-the-counter supplement ingredient, it occupies a legal grey area — it is not scheduled, but the FDA has issued warning letters to companies marketing it as a supplement. Self-experimentation with methylene blue should only be done with pharmaceutical-grade product at low doses (0.5-2 mg/kg), and it should not be combined with serotonergic medications (SSRIs, MAOIs) due to the risk of serotonin syndrome. At higher doses (above 5 mg/kg), methylene blue acts as a potent MAO inhibitor and carries significant risks.
The Science Behind Methylene Blue Nootropic Effects
Methylene blue is a phenothiazine dye that has been used in medicine for over 140 years — initially as an antimalarial, later as a treatment for methemoglobinemia and cyanide poisoning. Its nootropic properties emerged from observations that at low doses (0.5-4 mg/kg), it acts as an electron donor in the mitochondrial electron transport chain, specifically at Complex I (NADH dehydrogenase). By donating electrons directly to Complex I, methylene blue improves the efficiency of ATP production in neurons, reduces reactive oxygen species generation at Complex III, and enhances mitochondrial respiration. This is particularly relevant for neurons because they are highly energy-dependent and particularly vulnerable to mitochondrial dysfunction.
Memory and Long-Term Potentiation
Studies on animal models demonstrate that methylene blue at low doses enhances long-term potentiation (LTP) — the cellular basis of memory formation in the hippocampus. Methylene blue increases mitochondrial biogenesis in hippocampal neurons, improves calcium handling, and enhances synaptic plasticity-related gene expression. In humans, preliminary studies suggest improvements in short-term memory, working memory, and attention, particularly in tasks requiring sustained concentration. A 2015 study found that methylene blue improved fMRI BOLD signal in the prefrontal cortex during working memory tasks, suggesting increased neural efficiency in the circuits most important for executive function.
Safety and Legality
Methylene blue is FDA-approved for the treatment of methemoglobinemia and is available by prescription. As an over-the-counter supplement ingredient, it occupies a legal grey area — it is not scheduled, but the FDA has issued warning letters to companies marketing it as a supplement. Self-experimentation with methylene blue should only be done with pharmaceutical-grade product at low doses (0.5-2 mg/kg), and it should not be combined with serotonergic medications (SSRIs, MAOIs) due to the risk of serotonin syndrome. At higher doses (above 5 mg/kg), methylene blue acts as a potent MAO inhibitor and carries significant risks.
Leave a Reply